References
1. Dalen JE. Should patients with venous thromboembolism be screened for thrombophilia? Am J Med 2008;121:458–463.
2. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017:377: 1177–1187.
3. Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism. Advances in diagnosis and management. JAMA 2018;320:1583–1594.
4. Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006;355:1780–1789.
5. Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 2012;10:1019–1025.
6. Rodger MA, Kahn SR, Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulation therapy. CMAJ 2008;179:417–426.
7. Tapson VF, Platt DM, Xia F, et al. Monitoring for pulmonary hypertension following pulmonary embolism: the INFORM study. Am J Med 2016;129:978–985.
8. Pengo V. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257–2264.
9. Strijkers RHW, Cate-Hoek AJT, Bukkems SFFW, et al. Management of deep vein thrombosis and prevention of post-thrombotic syndrome. BMJ 2011;343;d5916.
10. Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post–thrombotic syndrome: a randomized placebo-controlled trial. Lancet 2014;383:880–888.
11. Mol GC, van de Ree MA, Klok FA, et al. One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomized controlled trial. BMJ 2016;353:i2691.
12. Hull RD, Liang J, Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med 2011;124:756–765.
13. Shah KP, Lee C, McBane RD, et al. Post-pulmonary embolism syndrome—a diagnostic dilemma and challenging management. Mayo Clin Proc 2024;99:1965–1982.
14. Aliberti S, Dela Cruz CS, Amati F, et al. Community-acquired pneumonia. Lancet 2021;398: 906–919.
15. Corrales-Medina VF, Musher DM, Shachkina S, et al. Acute pneumonia and the cardiovascular system. Lancet 2013;381:496–505.
16. Corrales-Medina MF, Taijaard M, Fine MJ, et al. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clin Proc 2014;89:60–68.
17. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75–80.
18. Rahman NM, Kahan BC, Miller RF, et al. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural effusion. Chest 2014;4:848–855.
19. Taylor JK, Fleming GB, Siganayagam A, et al. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med 2013;126:995–1001.
20. Peura DA, Lanza FL, Gostout CJ, et al. The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol 1997;92:924–928.
21. Qayed E, Dagar G, Nanchal RS. Lower gastrointestinal hemorrhage. Crit Care Clin 2016;32: 241–254.
22. Forrest JAH, Finlayson NDC, Sherman DJC. Endoscopy in gastrointestinal bleeding. Lancet 1974:304:394–397.
23. Laine L. Upper gastrointestinal bleeding due to a peptic ulcer. N Engl J Med 2016;374: 2367–2376.
24. Gralnek IM, Dumonceau JM, Kulpers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2015;47:1–46.
25. Chan FKL, Goh KL, Reddy N, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society of Digestive Endoscopy (APSDE) practice guidelines. Gut 2018;67:405–417.
26. Scott MJ, Veitch A, Thachil J. Reintroduction of anti-thrombotic therapy after a gastrointestinal haemorrhage: if and when? Br J Haematol 2017;177:185–197.
27. Fresenko LE, Rivera ZC, Parry SM, et al. Post-intensive care syndrome. Physical impairments and function. Crit Care Clin 2025;41:1–20.
28. Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med 2012;40: 502–509.
29. Brown SM, Wilson EL, Presson AP, et al. Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes. Thorax 2017;72:1094–1103.
30. Tilburgs B, Simons KS, Corsten S, et al. Association between physical, cognitive, and mental health domains of post-intensive care syndrome and quality of life: a longitudinal multicenter cohort study. Crit Care Med 2025;53:e74–e86.
31. Ferrante LE, Pisani MA, Murphy TE, et al. Factors associated with functional recovery among older intensive care unit survivors. Am J Respir Crit Care Med 2016;194:299–307.
32. McPeake J, Bateson M, Christie F, et al. Hospital re-admission after critical care survival: a systematic review and meta-analysis. Anaesthesia 2022;77:475–485.
33. Ehlenbach WJ, Hough CL, Crane PK, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA 2010;303:763–770.
34. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367–2375.
35. Smith AGC, Yarrington ME, Baker AW, et al. Beyond infection: mortality and end-of-life care associated with infectious disease consultation in an academic health system. Clin Infect Dis 2024;79:864–870.
36. Inouye SK, Peduzzi PN, Robison JT, et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998;279:1187–1193.
37. Landre B, Fayosse A, Hassen CB, et al. Terminal decline in objective and self-reported measures of motor function before death: 10 year follow-up of Whitehead II cohort study. BMJ 2021;374:n1743.
38. Ong KC, Earnest A. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005;128:3810–3816.
39. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 2001;285:2987–2994.
40. Tamura MK, Covinsky KE, Chertow GM, et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539–1547.
41. Walsh TS, Salisbury LG, Merriweather JL, et al. Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge. The RECOVER randomized clinical trial. JAMA Intern Med 2015;175:901–910.
42. Greysen SR, Cenzer IS, Auerbach AD, et al. Functional impairment and hospital readmission in Medicare seniors. JAMA Intern Med 2015;175:559–565.
43. Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med 2017;377;1456–1466.
44. Witlox J, Eureling LSM, de Jonghe JFM, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia. JAMA 2010;304:443–451.
45. Fong TG, Jones RN, Marcantonio ER, et al. Adverse outcomes after hospitalization and delirium in persons with Alzheimer disease. Ann Intern Med 2012;156:848–856.
46. Gross AL, Jones RN, Habtemariam DA, et al. Delirium and long-term cognitive trajectory among persons with dementia. Arch Intern Med 2012;172:1324–1331.
47. Pauley E, Lishmanov, A, Schumann, S, et al. Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit. Am Heart J 2015;170:76–86.
48. Humeidan ML, Reyes JPC, Mavarez-Martinez A, et al. Effect of cognitive prehabilitation on the incidence of postoperative delirium among older adults undergoing major noncardiac surgery. The Neurobics randomized clinical trial. JAMA Surg 2021;156:148–156.
49. Dodson JA, Truong TTN, Towle VR, et al. Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes. Am J Med 2013;126:120–126.
50. Zhang H, Jie Y, Sun Y, et al. Association of cognitive impairment with mortality and readmission in patients with heart failure: a meta-analysis. Curr Probl Cardiol 2022;47: 101354.
51. Goyal P, Didomenico RJ, Pressier SJ, et al. Cognitive impairment in heart failure: a Heart Failure Society of America Scientific Statement. J Card Fail 2024;30:488–504.
52. Whooley MA. Depression and cardiovascular disease. Healing the broken-hearted. JAMA 2006;295:2874–2881.
53. Nair N, Farmer C, Gongora E, et al. Commonality between depression and heart failure. Am J Cardiol 2012;109:768–772.
54. Cameron JI, Chu LM, Matte A, et al. One-year outcomes in caregiver of critically ill patients. N Engl J Med 2016;374:1831–1841.
55. Hooley PJD, Butler G, Howlett JG. The relationship of quality of life, depression, and caregiver burden in outpatients with congestive heart failure. Congest Heart Fail 2005;11: 303–310.
56. Bidwell JT, Higgins MK, Reilly CM, et al. Shared heart failure knowledge and self-care outcomes in patient-caregiver dyads. Heart Lung 2018:47:32–39.
57. Suksatan W, Tankumpuan T, Davidson PM. Heart failure caregiver burden and outcomes: a systematic review. J Prim Care Community Health 2022;13:1–19.
58. White DB, Angus DC, Shields AM, et al. A randomized trial of a family-support intervention in intensive care units. N Engl J Med 2018;378:2365–2375.
59. Spertus JA, Jones PG, Maron DJ, et al. Health-status outcomes with invasive or conservative care in coronary disease. N Engl J Med 2020;382:1408–1419.
60. Hochman JS, Anthopolos R, Reynolds HR, et al. Survival after invasive or conservative management of stable coronary disease. Circulation 2023;147:8–19.